Merck confirms shutting Bangalore Genei facility

German-based Pharmaceutical and Life Sciences organization, Merck KGaA, has shutdown its Bangalore site 02 – Bangalore GeNei facility


(Photo Courtesy:

The company confirmed with BioSpectrum that the production at the facility had been stopped since July 31, 2015, and that the decommissioning activities are in progress.

As part of Merck Millipore's (the life sciences tools division of Merck KGaA) strategy, it has been decided to stop supply of GeNei products and close the Merck Bangalore Site 02 - GeNei facility, said the company's spokeswoman.

GeNei was involved in the manufacturing of reagents, lab wares and chemicals, and was started by Dr P Babu in the eighties.

GeNei was later acquired by Merck in 2009, which was part of Sanmar Group, an Indian conglomerate MNC now valued at US $1 billion, headquartered in Chennai.

Sanmar's business sectors include chemicals, engineering, and shipping.


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email